Latest Conferences, Conference News

SABCS: Anastrozole Tied to Lasting Reduction in Breast Cancer Risk

Anastrozole is associated with a long-term reduction in breast cancer risk, even after treatment, according to a study published online Dec. 12 in The Lancet to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in Texas.

SABCS: Breast Cancer Rates Opposite for Estrogen, Estrogen + Progestin

For postmenopausal women, conjugated equine estrogen (CEE) alone is associated with a long-term decrease in breast cancer incidence, while CEE plus medroxyprogesterone acetate is associated with increased incidence, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in Texas.

SABCS: Long-Term Outcomes Good for PBI in Early Breast Cancer

For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation and whole breast irradiation, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in Texas.

Purified CBD May Help Treat Drug-Resistant Epilepsy

Among patients with tuberous sclerosis complex (TSC), the reduction in the frequency of TSC-associated seizures was greater in those receiving a purified version of cannabidiol than in those receiving placebo, according to a study presented at the annual meeting of the American Epilepsy Society, held from Dec. 6 to 10 in Baltimore.